Article Information
History
- November 16, 2022.
Article Versions
- Version 1 (July 14, 2021 - 13:04).
- Version 2 (July 15, 2021 - 09:13).
- Version 3 (July 16, 2021 - 09:49).
- You are viewing Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Annabelle Collin1,
- Boris P. Hejblum2,
- Carole Vignals3,
- Laurent Lehot2,
- Rodolphe Thiébaut3,
- Philippe Moireau4 and
- Mélanie Prague2,*
- 1Inria, Inria Bordeaux - Sud-Ouest, Bordeaux INP, IMB UMR 5251, IMB UMR 5251, Université Bordeaux, Talence, France
- 2Inria, Inria Bordeaux - Sud-Ouest, Talence, Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, SISTM Team, UMR 1219, F-33000 Bordeaux, Vaccine Research Institute, F-94000 Créteil, France
- 3Inria, Inria Bordeaux - Sud-Ouest, Talence, Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, SISTM Team, UMR 1219, F-33000 Bordeaux, Vaccine Research Institute, F-94000 Créteil, CHU Pellegrin, F-33000 Bordeaux, France
- 4Inria, Inria Saclay-Ile-de-France, LMS, CNRS UMR 77 07, Ecole Polytechnique, Institut Polytechnique de Paris, France
- ↵*Corresponding melanie.prague{at}inria.fr